Population Bio’s mission is to make drugs safer and more effective. We accelerate the delivery of precision medicine products to patients by discovering disease-relevant genetic biomarkers that enable:

Companion diagnostic test development to identify patients at risk of a serious adverse event (SAE) for currently marketed drugs.
Drug repurposing (repositioning) for new indications based on genetic subtypes of common diseases.
Drug rescue of promising therapies that fail in clinical trials for safety or efficacy.
Disease-modifying drug development for novel targets based on genetic discoveries (causal or protective variants).

Population Bio’s CNV Beacon® platform reduces the genome search space for faster, lower cost discovery of disease-relevant genes and variants.